Literature DB >> 16941343

Clinical manifestations of human monkeypox influenced by route of infection.

Mary G Reynolds1, Krista L Yorita, Mathew J Kuehnert, Whitni B Davidson, Gregory D Huhn, Robert C Holman, Inger K Damon.   

Abstract

BACKGROUND: In April 2003, an outbreak of monkeypox occurred in the United States following the importation of monkeypox virus (MPXV)-infected animals in a consignment of exotic pets from West Africa. Transmission of the virus to non-African captive species, including prairie dogs, preceded human disease.
METHODS: We evaluated the influence of the route of infection on clinical illness for persons with confirmed and probable cases of human monkeypox. Exposures were categorized as being "noninvasive" (e.g., the person touched an infected animal, cleaned an infected animal's cage, and/or stood within 6 feet of an infected animal) or "complex" (e.g., invasive bite or scratch from an ill prairie dog plus potential noninvasive exposure), and associations between exposure, illness manifestation, and illness progression (i.e., elapsed time from first exposure to an ill prairie dog through various benchmarks of illness) were assessed.
RESULTS: Patients with complex exposures were more likely than patients with noninvasive exposures to have experienced pronounced signs of systemic illness (49.1% vs. 16.7%; P=.041) and to have been hospitalized during illness (68.8% vs. 10.3%; P<.001). Complex exposures were also associated with shorter incubation periods (9 days for complex exposures vs. 13 days for noninvasive exposures) and the absence of a distinct febrile prodrome.
CONCLUSIONS: The findings of this study indicate that route of infection can influence monkeypox illness manifestations.

Entities:  

Mesh:

Year:  2006        PMID: 16941343     DOI: 10.1086/505880

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  84 in total

1.  Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges.

Authors:  M S Keckler; D S Carroll; N F Gallardo-Romero; R R Lash; J S Salzer; S L Weiss; N Patel; C J Clemmons; S K Smith; C L Hutson; K L Karem; I K Damon
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

Authors:  Megan M McCausland; Mohammed Rafii-El-Idrissi Benhnia; Lindsay Crickard; John Laudenslager; Steven W Granger; Tomoyuki Tahara; Ralph Kubo; Lilia Koriazova; Shinichiro Kato; Shane Crotty
Journal:  Antivir Ther       Date:  2010

3.  Group 1 Vaccinia virus zoonotic outbreak in Maranhao State, Brazil.

Authors:  Danilo Bretas Oliveira; Felipe Lopes Assis; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Am J Trop Med Hyg       Date:  2013-10-28       Impact factor: 2.345

4.  Evaluation of monkeypox disease progression by molecular imaging.

Authors:  Julie Dyall; Reed F Johnson; Dar-Yeong Chen; Louis Huzella; Dan R Ragland; Daniel J Mollura; Russell Byrum; Richard C Reba; Gerald Jennings; Peter B Jahrling; Joseph E Blaney; Jason Paragas
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

Review 5.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

6.  Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.

Authors:  Reed F Johnson; Dima A Hammoud; Donna L Perry; Jeffrey Solomon; Ian N Moore; Matthew G Lackemeyer; Jordan K Bohannon; Philip J Sayre; Mahnaz Minai; Amy B Papaneri; Katie R Hagen; Krisztina B Janosko; Catherine Jett; Kurt Cooper; Joseph E Blaney; Peter B Jahrling
Journal:  J Gen Virol       Date:  2016-05-09       Impact factor: 3.891

7.  Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection.

Authors:  Kevin L Karem; Mary Reynolds; Christine Hughes; Zach Braden; Pragati Nigam; Shane Crotty; John Glidewell; Rafi Ahmed; Rama Amara; Inger K Damon
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

8.  Comparison of West African and Congo Basin monkeypox viruses in BALB/c and C57BL/6 mice.

Authors:  Christina L Hutson; Jason A Abel; Darin S Carroll; Victoria A Olson; Zachary H Braden; Christine M Hughes; Michael Dillon; Consuelo Hopkins; Kevin L Karem; Inger K Damon; Jorge E Osorio
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

9.  One more piece in the VACV ecological puzzle: could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil?

Authors:  Jônatas S Abrahão; Maria Isabel M Guedes; Giliane S Trindade; Flávio G Fonseca; Rafael K Campos; Bruno F Mota; Zélia I P Lobato; André T Silva-Fernandes; Gisele O L Rodrigues; Larissa S Lima; Paulo C P Ferreira; Cláudio A Bonjardim; Erna G Kroon
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

10.  Spectrum of infection and risk factors for human monkeypox, United States, 2003.

Authors:  Mary G Reynolds; Whitni B Davidson; Aaron T Curns; Craig S Conover; Gregory Huhn; Jeffrey P Davis; Mark Wegner; Donita R Croft; Alexandra Newman; Nkolika N Obiesie; Gail R Hansen; Patrick L Hays; Pamela Pontones; Brad Beard; Robert Teclaw; James F Howell; Zachary Braden; Robert C Holman; Kevin L Karem; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.